Found: 80
Select item for more details and to access through your institution.
Identification of a central network hub of key prognostic genes based on correlation between transcriptomics and survival in patients with metastatic solid tumors.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241289200
- By:
- Publication type:
- Article
Indirect Treatment Comparison of Larotrectinib versus Entrectinib in Treating Patients with TRK Gene Fusion Cancers.
- Published in:
- Cancers, 2022, v. 14, n. 7, p. 1793, doi. 10.3390/cancers14071793
- By:
- Publication type:
- Article
Larotrectinib versus Prior Therapies in Tropomyosin Receptor Kinase Fusion Cancer: An Intra-Patient Comparative Analysis.
- Published in:
- Cancers, 2020, v. 12, n. 11, p. 3246, doi. 10.3390/cancers12113246
- By:
- Publication type:
- Article
Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols.
- Published in:
- Clinical Laboratory, 2017, n. 10, p. 1755, doi. 10.7754/Clin.Lab.2017.170516
- By:
- Publication type:
- Article
Precision cancer medicine: Concepts, current practice, and future developments.
- Published in:
- Journal of Internal Medicine, 2023, v. 294, n. 4, p. 455, doi. 10.1111/joim.13709
- By:
- Publication type:
- Article
Supporting Biomarker-Driven Therapies in Oncology: A Genomic Testing Cost Calculator.
- Published in:
- Oncologist, 2023, v. 28, n. 5, p. e242, doi. 10.1093/oncolo/oyad005
- By:
- Publication type:
- Article
Phase 1 dose-escalation study of the antiplacental growth factor monoclonal antibody RO5323441 combined with bevacizumab in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 7, p. 1007, doi. 10.1093/neuonc/nov019
- By:
- Publication type:
- Article
Cetuximab, bevacizumab, and irinotecan for patients with primary glioblastoma and progression after radiation therapy and temozolomide: a phase II trial.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 5, p. 508
- By:
- Publication type:
- Article
Extracranial metastases in glioblastoma—Two case stories.
- Published in:
- Clinical Case Reports, 2019, v. 7, n. 2, p. 289, doi. 10.1002/ccr3.1980
- By:
- Publication type:
- Article
Capture and Detection of Circulating Glioma Cells Using the Recombinant VAR2CSA Malaria Protein.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 9, p. 998, doi. 10.3390/cells8090998
- By:
- Publication type:
- Article
Changes in key recruitment performance metrics from 2008–2019 in industry-sponsored phase III clinical trials registered at ClinicalTrials.gov.
- Published in:
- PLoS ONE, 2022, v. 17, n. 7, p. 1, doi. 10.1371/journal.pone.0271819
- By:
- Publication type:
- Article
Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Neoepitope load, T cell signatures and PD-L2 as combined biomarker strategy for response to checkpoint inhibition immunotherapy.
- Published in:
- Frontiers in Genetics, 2023, v. 14, p. 1, doi. 10.3389/fgene.2023.1058605
- By:
- Publication type:
- Article
Detecting and Targeting NTRK Fusions in Cancer in the Era of Tumor Agnostic Oncology.
- Published in:
- Drugs, 2021, v. 81, n. 4, p. 445, doi. 10.1007/s40265-020-01459-w
- By:
- Publication type:
- Article
Comorbidity between lung cancer and COVID-19 pneumonia: role of immunoregulatory gene transcripts in high ACE2 -expressing normal lung.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221133893
- By:
- Publication type:
- Article
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer.
- Published in:
- American Journal of Managed Care, 2022, v. 28, p. S26, doi. 10.37765/ajmc.2022.88845
- By:
- Publication type:
- Article
Diagnosis and Management of TRK Fusion Cancer.
- Published in:
- American Journal of Managed Care, 2022, v. 28, p. S15, doi. 10.37765/ajmc.2022.88834
- By:
- Publication type:
- Article
Comparative Effectiveness of Larotrectinib and Entrectinib for TRK Fusion Cancer.
- Published in:
- American Journal of Managed Care, 2022, v. 28, p. S26, doi. 10.37765/ajmc.2022.88845
- By:
- Publication type:
- Article
Diagnosis and Management of TRK Fusion Cancer.
- Published in:
- American Journal of Managed Care, 2022, v. 28, p. S15, doi. 10.37765/ajmc.2022.88834
- By:
- Publication type:
- Article
Total burden of disease in cancer patients at diagnosis-a Danish nationwide study of multimorbidity and redeemed medication.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
ProTarget: a Danish Nationwide Clinical Trial on Targeted Cancer Treatment based on genomic profiling – a national, phase 2, prospective, multi-drug, non-randomized, open-label basket trial.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10632-9
- By:
- Publication type:
- Article
Natriuretic peptides in the monitoring of anthracycline induced reduction in left ventricular ejection fraction
- Published in:
- European Journal of Heart Failure, 2005, v. 7, n. 1, p. 87, doi. 10.1016/j.ejheart.2004.03.009
- By:
- Publication type:
- Article
Patient information in phase 1 trials: A systematic review.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Preoperative staging of lung cancer with PET/CT: cost-effectiveness evaluation alongside a randomized controlled trial.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 5, p. 802, doi. 10.1007/s00259-010-1703-y
- By:
- Publication type:
- Article
Immunotherapy drives mesenchymal tumor cell state shift and TME immune response in glioblastoma patients.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 8, p. 1453, doi. 10.1093/neuonc/noae085
- By:
- Publication type:
- Article
Radiotherapy combined with nivolumab or temozolomide for newly diagnosed glioblastoma with unmethylated MGMT promoter: An international randomized phase III trial.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 1, p. 123, doi. 10.1093/neuonc/noac099
- By:
- Publication type:
- Article
PATH-21. ANGIOTENSINOGEN GENE SILENCING PREDICTS BEVACIZUMAB RESPONSE IN RECURRENT GLIOBLASTOMA PATIENTS.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi162, doi. 10.1093/neuonc/noy148.677
- By:
- Publication type:
- Article
GENE-30. INCREASED TUMOR MUTATIONAL LOAD AFTER RADIOTHERAPY AND TEMOZOLOMIDE IN PROGRESSING GLIOBLASTOMA A PROSPECTIVE STUDY.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi109, doi. 10.1093/neuonc/noy148.456
- By:
- Publication type:
- Article
Impact of multimorbidity and polypharmacy on mortality after cancer: a nationwide registry-based cohort study in Denmark 2005–2017.
- Published in:
- Acta Oncologica, 2023, v. 62, n. 12, p. 1653, doi. 10.1080/0284186X.2023.2270145
- By:
- Publication type:
- Article
Extensive genomic analysis in patients with KRAS-mutated solid tumors shows high frequencies of concurrent alterations and potential targets but has limited clinical impact.
- Published in:
- Acta Oncologica, 2022, v. 61, n. 12, p. 1499, doi. 10.1080/0284186X.2022.2156809
- By:
- Publication type:
- Article
Late effects – the new focus of follow-up.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Patients in phase 1 cancer trials: psychological distress and understanding of trial information.
- Published in:
- Acta Oncologica, 2022, v. 61, n. 3, p. 341, doi. 10.1080/0284186X.2021.1993331
- By:
- Publication type:
- Article
Larotrectinib efficacy and safety in adult patients with tropomyosin receptor kinase fusion sarcomas.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3772, doi. 10.1002/cncr.35036
- By:
- Publication type:
- Article
Phase 1 study of the immunotoxin LMB‐100 in patients with mesothelioma and other solid tumors expressing mesothelin.
- Published in:
- Cancer (0008543X), 2020, v. 126, n. 22, p. 4936, doi. 10.1002/cncr.33145
- By:
- Publication type:
- Article
Sorafenib in Advanced Hepatocellular Carcinoma: A Nationwide Retrospective Study of Efficacy and Tolerability.
- Published in:
- Scientific World Journal, 2013, p. 1, doi. 10.1155/2013/931972
- By:
- Publication type:
- Article
A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A drug-drug interaction study to assess the effect of the CYP1A2 inhibitor fluvoxamine on the pharmacokinetics of dovitinib (TKI258) in patients with advanced solid tumors.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study.
- Published in:
- Oncology, 2022, v. 100, n. 2, p. 124, doi. 10.1159/000519767
- By:
- Publication type:
- Article
Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor (Adv. Healthcare Mater. 1/2022).
- Published in:
- Advanced Healthcare Materials, 2022, v. 11, n. 1, p. 1, doi. 10.1002/adhm.202270001
- By:
- Publication type:
- Article
Modeling Metastatic Colonization in a Decellularized Organ Scaffold‐Based Perfusion Bioreactor.
- Published in:
- Advanced Healthcare Materials, 2022, v. 11, n. 1, p. 1, doi. 10.1002/adhm.202100684
- By:
- Publication type:
- Article
Convergent Akt activation drives acquired EGFR inhibitor resistance in lung cancer.
- Published in:
- Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00450-6
- By:
- Publication type:
- Article
<sup>18</sup>F-FET MicroPET and MicroMRI for Anti-VEGF and Anti-PlGF Response Assessment in an Orthotopic Murine Model of Human Glioblastoma.
- Published in:
- PLoS ONE, 2015, v. 10, n. 2, p. 1, doi. 10.1371/journal.pone.0115315
- By:
- Publication type:
- Article
The Use of Longitudinal <sup>18</sup>F-FET MicroPET Imaging to Evaluate Response to Irinotecan in Orthotopic Human Glioblastoma Multiforme Xenografts.
- Published in:
- PLoS ONE, 2014, v. 9, n. 6, p. 1, doi. 10.1371/journal.pone.0100009
- By:
- Publication type:
- Article
Phase Ib study evaluating safety and clinical activity of the anti-HER3 antibody lumretuzumab combined with the anti-HER2 antibody pertuzumab and paclitaxel in HER3-positive, HER2-low metastatic breast cancer.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 848, doi. 10.1007/s10637-018-0562-4
- By:
- Publication type:
- Article
Characteristics of de novo cancer in liver transplant recipients.
- Published in:
- APMIS, 2023, v. 131, n. 4, p. 135, doi. 10.1111/apm.13296
- By:
- Publication type:
- Article
Personalized oncology: genomic screening in phase 1.
- Published in:
- APMIS, 2014, v. 122, n. 8, p. 723, doi. 10.1111/apm.12293
- By:
- Publication type:
- Article
Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan.
- Published in:
- APMIS, 2010, v. 118, n. 8, p. 585, doi. 10.1111/j.1600-0463.2010.02631.x
- By:
- Publication type:
- Article
'Plumb line scribe': Using multimedia to preserve traditional craft skills.
- Published in:
- Craft Research, 2013, v. 4, n. 1, p. 31, doi. 10.1386/crre.4.1.31_1
- By:
- Publication type:
- Article